Abbott Laboratories (ABT)

Abbott Laboratories Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Quarter	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	8,522	7,511	6,951	6,532	7,616	7,558	6,987	6,284	6,896	6,709	7,835	9,161	9,882	9,594	8,937	7,675	9,799	9,302	8,658	8,054
Short-Term Investments	417	222	331	312	351	230	232	367	383	338	320	371	288	313	353	483	450	390	286	318
Cash & Short-Term Investments	8,939	7,733	7,282	6,844	7,967	7,788	7,219	6,651	7,279	7,047	8,155	9,532	10,170	9,907	9,290	8,158	10,249	9,692	8,944	8,372
Cash Growth	12.20%	-0.71%	0.87%	2.90%	9.45%	10.51%	-11.48%	-30.23%	-28.43%	-28.87%	-12.22%	16.84%	-0.77%	2.22%	3.87%	-2.56%	43.38%	104.86%	77.57%	128.24%
Accounts Receivable	7,929	8,138	7,972	7,327	6,925	7,051	6,854	6,605	6,565	6,499	6,172	6,020	6,218	6,408	7,199	7,179	6,487	6,405	6,113	6,096
Other Receivables	2,640	2,260	2,260	2,343	2,570	2,150	2,232	2,293	2,256	2,468	2,307	2,152	2,663	2,796	2,568	2,401	2,346	2,134	2,131	1,962
Total Trade Receivables	10,569	10,398	10,232	9,670	9,495	9,201	9,086	8,898	8,821	8,967	8,479	8,172	8,881	9,204	9,767	9,580	8,833	8,539	8,244	8,058
Inventory	6,488	6,708	6,954	6,639	6,194	6,813	6,814	6,827	6,570	6,650	6,871	6,673	6,173	5,734	5,899	5,691	5,157	5,261	5,439	5,387
Other Current Assets	2,640	2,260	2,260	2,343	2,570	2,150	2,232	2,293	2,256	2,468	2,307	2,152	2,663	2,796	2,568	2,401	2,346	2,134	2,131	1,962
Total Current Assets	25,996	24,839	24,468	23,153	23,656	23,802	23,119	22,376	22,670	22,664	23,505	24,377	25,224	24,845	24,956	23,429	24,239	23,492	22,627	21,817
Net Property, Plant & Equipment	37,038	11,504	11,395	10,932	33,398	10,621	10,233	10,107	32,087	9,552	9,449	9,282	29,374	8,689	8,818	8,908	28,323	8,831	8,816	8,832
Other Intangible Assets	5,526	5,598	5,920	6,261	6,647	7,352	7,827	8,296	8,815	9,282	9,834	10,006	10,454	10,850	11,592	12,225	12,739	13,312	13,681	14,181
Goodwill	24,035	23,971	23,952	23,359	23,108	23,658	23,308	23,383	23,679	23,277	23,258	22,927	22,799	22,284	22,744	23,179	23,231	23,299	23,485	23,384
Long-Term Investments	918	951	958	907	886	912	877	818	799	788	799	776	766	764	734	763	816	812	805	832
Other Long-Term Assets	18,422	17,318	17,306	16,836	16,459	8,011	7,653	7,487	7,097	6,527	6,509	6,426	6,033	5,369	5,358	5,503	5,212	4,049	3,855	3,739
Total Assets	86,713	84,181	83,999	81,448	81,414	74,356	73,017	72,467	73,214	72,090	73,354	73,794	74,438	72,801	74,202	74,007	75,196	73,795	73,269	72,785
Accounts Payable	4,240	4,123	4,306	4,214	4,195	4,034	4,125	4,178	4,295	3,961	4,211	4,167	4,607	4,133	4,493	4,757	4,408	4,017	4,017	4,066
Accrued Expenses	7,557	7,615	7,206	6,767	6,844	7,045	6,460	6,312	7,019	6,826	6,696	6,856	7,401	6,901	6,715	6,724	6,806	6,734	6,602	6,364
Short-Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	197	199	199
Current Portion of Long-Term Debt	3,033	1,345	507	506	1,500	2,154	1,615	2,010	1,080	1,051	2,284	2,285	2,251	1,117	5	4	754	754	755	756
Other Current Liabilities	1,666	1,499	1,420	1,517	1,618	1,669	1,560	1,521	1,447	1,204	1,159	1,222	1,230	1,214	1,179	1,162	1,137	1,165	1,041	1,077
Total Current Liabilities	16,496	14,582	13,439	13,004	14,157	14,902	13,760	14,021	13,841	13,042	14,350	14,530	15,489	13,365	12,392	12,647	13,105	12,867	12,614	12,462
Long-Term Debt	9,896	11,596	12,930	12,736	12,625	12,825	13,139	12,576	13,599	14,477	14,562	14,615	14,522	15,297	16,755	17,086	17,296	17,446	17,547	17,489
Other Long-Term Liabilities	7,550	6,739	6,801	6,644	6,731	6,601	6,558	6,827	6,947	6,877	7,038	7,417	7,522	8,255	8,339	8,645	8,771	8,844	9,079	9,046
Total Long-Term Liabilities	17,446	18,335	19,731	19,380	19,356	19,426	19,697	19,403	20,546	21,354	21,600	22,032	22,044	23,552	25,094	25,731	26,067	26,290	26,626	26,535
Total Liabilities	33,942	32,917	33,170	32,384	33,513	34,328	33,457	33,424	34,387	34,396	35,950	36,562	37,533	36,917	37,486	38,378	39,172	39,157	39,240	38,997
Common Stock	25,527	25,412	25,284	25,125	25,153	25,020	24,858	24,726	24,869	24,727	24,612	24,488	24,709	24,560	24,429	24,304	24,470	24,285	24,153	24,023
Treasury Stock	-17,177	-16,877	-16,610	-16,612	-16,844	-16,476	-15,759	-15,761	-15,981	-15,686	-15,722	-15,307	-15,229	-14,555	-13,720	-13,726	-11,822	-10,999	-10,340	-9,845
Accumulated Other Comprehensive Income	-6,001	-6,684	-6,576	-7,417	-7,906	-7,804	-8,135	-8,166	-7,839	-8,480	-8,071	-8,039	-8,051	-9,445	-8,706	-8,474	-8,374	-9,240	-9,066	-9,285
Retained Earnings	49,781	49,103	48,467	47,715	47,261	39,056	38,354	38,011	37,554	36,920	36,355	35,868	35,257	35,115	34,487	33,295	31,528	30,376	29,053	28,669
Total Common Shareholders' Equity	52,130	50,954	50,565	48,811	47,664	39,796	39,318	38,810	38,603	37,481	37,174	37,010	36,686	35,675	36,490	35,399	35,802	34,422	33,800	33,562
Minority Interest	641	310	264	253	237	232	242	233	224	213	230	222	219	209	226	230	222	216	229	226
Shareholders' Equity	52,771	51,264	50,829	49,064	47,901	40,028	39,560	39,043	38,827	37,694	37,404	37,232	36,905	35,884	36,716	35,629	36,024	34,638	34,029	33,788
Total Liabilities & Equity	86,713	84,181	83,999	81,448	81,414	74,356	73,017	72,467	73,214	72,090	73,354	73,794	74,438	72,801	74,202	74,007	75,196	73,795	73,269	72,785
Total Debt	12,929	12,941	13,437	13,242	14,125	14,979	14,754	14,586	14,679	15,528	16,846	16,900	16,773	16,414	16,760	17,090	18,050	18,397	18,501	18,444
Net Cash (Debt)	-3,990	-5,208	-6,155	-6,398	-6,158	-7,191	-7,535	-7,935	-7,400	-8,481	-8,691	-7,368	-6,603	-6,507	-7,470	-8,932	-7,801	-8,705	-9,557	-10,072
Net Cash Per Share	-2.28	-2.98	-3.52	-3.66	-3.53	-4.12	-4.30	-4.54	-4.23	-4.85	-4.97	-4.21	-3.74	-3.69	-4.23	-5.03	-4.37	-4.87	-5.33	-5.62
Book Value	52,130	50,954	50,565	48,811	47,664	39,796	39,318	38,810	38,603	37,481	37,174	37,010	36,686	35,675	36,490	35,399	35,802	34,422	33,800	33,562
Book Value Per Share	29.84	29.13	28.88	27.94	27.30	22.77	22.45	22.18	22.08	21.44	21.24	21.13	20.77	20.23	20.67	19.95	20.07	19.24	18.85	18.73
Tangible Book Value	22,569	21,385	20,693	19,191	17,909	8,786	8,183	7,131	6,109	4,922	4,082	4,077	3,433	2,541	2,154	-5	-168	-2,189	-3,366	-4,003
Tangible Book Value Per Share	12.92	12.22	11.82	10.98	10.26	5.03	4.67	4.08	3.49	2.82	2.33	2.33	1.94	1.44	1.22	-0.00	-0.09	-1.22	-1.88	-2.23

Updated Jan 22, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q